This is a key step forward in our commitment to meeting the needs of our global clients!
Many of our clients in Korea and China export their products to Southeast Asia and the Middle East, regions with islamic community. With 60-70% of the world’s Muslim population living in Asia, this certification has become a growing demand from our partners.
👉 By obtaining this certification for DNA and HANa, we enable our clients to meet market requirements, expand into these regions and take another step towards inclusivity.
At HTL Biotechnology, we are dedicated to providing high-quality products that respect the cultural standards and meet the regulatory standards of all our customers, wherever they are.
To see our most recent news,
Read more
news from us
-
Articles October 3, 2024
HTL Biotechnology will launch its White Paper at CPHI Milan!
We are excited to announce that the HTL Biotechnology team will be attending CPHI Milan and on this occasion, we will be launching our White Paper to celebrate 90 years of discovery of Hyaluronic Acid!
-
Articles July 5, 2024
HTL Biotechnology Secures Medical Device Registration in China
Sodium DNA Raw Material Main Document (Polynucleotides) registered as a medical device (number M2024199-000) in China.
-
Articles June 21, 2024
HTL Biotechnology at CPHI China 2024
CPHI China is one of Asia’s leading Pharma events for trading and networking with 3,500+ exhibitors and 90,000+ professionals from the pharmaceutical industry,